Annogen BV

Exhibitor

At Annogen we use our SuRE™ technology to identify and develop bespoke human regulatory DNA elements to be used for controlled (therapeutic) gene expression for gene & cell therapy. The SuRE™ technology is also applied to identify regulatory elements from the cell line specific genome for recombinant protein production. In addition, we offer the AIM™ service to identify favorable gene insertions and their expression levels for more than 100,000 integrations in parallel. These approaches typically enable big improvements in any biomedical strategy involving the (over-) expression of genes. For more information, please visit www.annogen.bio.



Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit


Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

 

To speak


Ila Dickinson
ila.dickinson@terrapinn.com
+44 207 092 1150